These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 31177401

  • 1. CKT0353, a novel microtubule targeting agent, overcomes paclitaxel induced resistance in cancer cells.
    Dinić J, Ríos-Luci C, Karpaviciene I, Cikotiene I, Fernandes MX, Pešić M, Padrón JM.
    Invest New Drugs; 2020 Jun; 38(3):584-598. PubMed ID: 31177401
    [Abstract] [Full Text] [Related]

  • 2. 2-APCAs, the Novel Microtubule Targeting Agents Active Against Distinct Cancer Cell Lines.
    Boichuk S, Galembikova A, Bikinieva F, Dunaev P, Aukhadieva A, Syuzov K, Zykova S, Igidov N, Ksenofontov A, Bocharov P.
    Molecules; 2021 Jan 25; 26(3):. PubMed ID: 33503939
    [Abstract] [Full Text] [Related]

  • 3. 5-(3,4,5-trimethoxybenzoyl)-4-methyl-2-(p-tolyl) imidazol (BZML) targets tubulin and DNA to induce anticancer activity and overcome multidrug resistance in colorectal cancer cells.
    Bai Z, Liu X, Guan Q, Ding N, Wei Q, Tong B, Zhao M, Zhang W, Ma L.
    Chem Biol Interact; 2020 Jan 05; 315():108886. PubMed ID: 31682804
    [Abstract] [Full Text] [Related]

  • 4. BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe.
    Bai Z, Gao M, Zhang H, Guan Q, Xu J, Li Y, Qi H, Li Z, Zuo D, Zhang W, Wu Y.
    Cancer Lett; 2017 Aug 28; 402():81-92. PubMed ID: 28576750
    [Abstract] [Full Text] [Related]

  • 5. DTA0100, dual topoisomerase II and microtubule inhibitor, evades paclitaxel resistance in P-glycoprotein overexpressing cancer cells.
    Podolski-Renić A, Banković J, Dinić J, Ríos-Luci C, Fernandes MX, Ortega N, Kovačević-Grujičić N, Martín VS, Padrón JM, Pešić M.
    Eur J Pharm Sci; 2017 Jul 15; 105():159-168. PubMed ID: 28502672
    [Abstract] [Full Text] [Related]

  • 6. YAN, a novel microtubule inhibitor, inhibits P-gp and MRP1 function and induces mitotic slippage followed by apoptosis in multidrug-resistant A549/Taxol cells.
    Gao M, Liu T, Li J, Guan Q, Wang H, Yan S, Li Z, Zuo D, Zhang W, Wu Y.
    Toxicol In Vitro; 2020 Dec 15; 69():104971. PubMed ID: 32805372
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Development of a novel class of tubulin inhibitor from desmosdumotin B with a hydroxylated bicyclic B-ring.
    Nakagawa-Goto K, Oda A, Hamel E, Ohkoshi E, Lee KH, Goto M.
    J Med Chem; 2015 Mar 12; 58(5):2378-89. PubMed ID: 25695315
    [Abstract] [Full Text] [Related]

  • 9. A semisynthetic taxane Yg-3-46a effectively evades P-glycoprotein and β-III tubulin mediated tumor drug resistance in vitro.
    Cai P, Lu P, Sharom FJ, Fang WS.
    Cancer Lett; 2013 Dec 01; 341(2):214-23. PubMed ID: 23941826
    [Abstract] [Full Text] [Related]

  • 10. Identification and optimization of biphenyl derivatives as novel tubulin inhibitors targeting colchicine-binding site overcoming multidrug resistance.
    Cheng B, Zhu G, Meng L, Wu G, Chen Q, Ma S.
    Eur J Med Chem; 2022 Jan 15; 228():113930. PubMed ID: 34794817
    [Abstract] [Full Text] [Related]

  • 11. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines.
    Ling YH, Jiang JD, Holland JF, Perez-Soler R.
    Mol Pharmacol; 2002 Sep 15; 62(3):529-38. PubMed ID: 12181429
    [Abstract] [Full Text] [Related]

  • 12. Identification of a lathyrane-type diterpenoid EM-E-11-4 as a novel paclitaxel resistance reversing agent with multiple mechanisms of action.
    Liu Q, Cai P, Guo S, Shi J, Sun H.
    Aging (Albany NY); 2020 Feb 28; 12(4):3713-3729. PubMed ID: 32108588
    [Abstract] [Full Text] [Related]

  • 13. Identification and characterization of SSE15206, a microtubule depolymerizing agent that overcomes multidrug resistance.
    Manzoor S, Bilal A, Khan S, Ullah R, Iftikhar S, Emwas AH, Alazmi M, Gao X, Jawaid A, Saleem RSZ, Faisal A.
    Sci Rep; 2018 Feb 19; 8(1):3305. PubMed ID: 29459693
    [Abstract] [Full Text] [Related]

  • 14. 2-Phenyl-5-(pyrrolidin-1-yl)-1-(3,4,5-trimethoxybenzyl)-1H-benzimidazole, a benzimidazole derivative, inhibits growth of human prostate cancer cells by affecting tubulin and c-Jun N-terminal kinase.
    Chang WL, Chang CS, Chiang PC, Ho YF, Liu JF, Chang KW, Guh JH.
    Br J Pharmacol; 2010 Aug 19; 160(7):1677-89. PubMed ID: 20649571
    [Abstract] [Full Text] [Related]

  • 15. (Z)-1-aryl-3-arylamino-2-propen-1-ones, highly active stimulators of tubulin polymerization: synthesis, structure-activity relationship (SAR), tubulin polymerization, and cell growth inhibition studies.
    Reddy MV, Akula B, Cosenza SC, Lee CM, Mallireddigari MR, Pallela VR, Subbaiah DR, Udofa A, Reddy EP.
    J Med Chem; 2012 Jun 14; 55(11):5174-87. PubMed ID: 22587519
    [Abstract] [Full Text] [Related]

  • 16. Selective Inhibition of Spindle Microtubules by a Tubulin-Binding Quinazoline Derivative.
    Sawada JI, Ishii H, Matsuno K, Sato M, Suzuki Y, Asai A.
    Mol Pharmacol; 2019 Nov 14; 96(5):609-618. PubMed ID: 31471455
    [Abstract] [Full Text] [Related]

  • 17. Dietary flavonoid fisetin binds to β-tubulin and disrupts microtubule dynamics in prostate cancer cells.
    Mukhtar E, Adhami VM, Sechi M, Mukhtar H.
    Cancer Lett; 2015 Oct 28; 367(2):173-83. PubMed ID: 26235140
    [Abstract] [Full Text] [Related]

  • 18. Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo.
    Wong VK, Chiu P, Chung SS, Chow LM, Zhao YZ, Yang BB, Ko BC.
    Clin Cancer Res; 2005 Aug 15; 11(16):6002-11. PubMed ID: 16115945
    [Abstract] [Full Text] [Related]

  • 19. 6,7-Dimethoxy-3-(3-methoxyphenyl)isoquinolin-1-amine induces mitotic arrest and apoptotic cell death through the activation of spindle assembly checkpoint in human cervical cancer cells.
    Chung KS, Choi HE, Shin JS, Cho YW, Choi JH, Cho WJ, Lee KT.
    Carcinogenesis; 2013 Aug 15; 34(8):1852-60. PubMed ID: 23615402
    [Abstract] [Full Text] [Related]

  • 20. Novel microtubule-targeting agents, pyrrolo-1,5-benzoxazepines, induce apoptosis in multi-drug-resistant cancer cells.
    Nathwani SM, Butler S, Fayne D, McGovern NN, Sarkadi B, Meegan MJ, Lloyd DG, Campiani G, Lawler M, Williams DC, Zisterer DM.
    Cancer Chemother Pharmacol; 2010 Aug 15; 66(3):585-96. PubMed ID: 20020128
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.